Abatacept is Efficacious in the Treatment of Older Patients with csDMARD-Refractory Rheumatoid Arthritis: A Prospective, Multicenter, Observational Study-Reference-Cited by-同舟云学术

Abatacept is Efficacious in the Treatment of Older Patients with csDMARD-Refractory Rheumatoid Arthritis: A Prospective, Multicenter, Observational Study

Published:2021-08-26 Issue:4 Volume:8 Page:1585-1601
ISSN:2198-6576
Container-title:Rheumatology and Therapy
language:en
Short-container-title:Rheumatol Ther

Author:

Muraoka Sei^ORCID,Yamada Zento^ORCID,Kawazoe Mai,Hirose Wataru^ORCID,Kono Hajime^ORCID,Yasuda Shinsuke^ORCID,Komano Yukiko^ORCID,Kawano Hiroshi^ORCID,Hidaka Toshihiko,Nakashima Shusaku^ORCID,Kasama Tsuyoshi^ORCID,Teramoto Tamio,Nanki Toshihiro^ORCID,

Funder

Bristol-Myers Squibb

Ono Pharmaceutical

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40744-021-00356-2.pdf

Reference51 articles.

1. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205–19.

2. Grigor C, Capell H, Stirling A, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet. 2004;364(9430):263–9.

3. Ng B, Chu A, Khan MM. A retrospective cohort study: 10-year trend of disease-modifying antirheumatic drugs and biological agents use in patients with rheumatoid arthritis at Veteran Affairs Medical Centers. BMJ Open. 2013;3(4):e002468.

4. Boots AMH, Maier AB, Stinissen P, et al. The influence of ageing on the development and management of rheumatoid arthritis. Nat Rev Rheumatol. 2013;9(10):604–13.